Abstract-The role of fibrinogen in cardiovascular disease has been extensively studied, and meta-analyses have definitively confirmed that high levels of fibrinogen are associated with an increased risk of the disease. In recent years, several polymorphisms have been identified in the fibrinogen chain genes that contribute to determine the levels of fibrinogen in the general population. The fibrinogen -chain gene has been more extensively studied because the -chain synthesis is the limiting step in the production of mature fibrinogen. Overall, the studies show an association between -fibrinogen chain polymorphisms and the levels of fibrinogen. In contrast, the majority of the studies did not find any relation with the risk of cardiovascular disease. The individual responses to gender or to environmental stimuli such as smoking, physical exercise, or infections may be genetically determined, and genetic variability underlies changes in biological reactions that contribute to differences in cardiovascular risk. In the future, gene-environment interactions should be considered in evaluating the relevance of genetic variations on the risk of cardiovascular disease. Key Words: fibrinogen Ⅲ polymorphisms Ⅲ gene-environment interactions Ⅲ risk factors Ⅲ cardiovascular disease A fter the first evidence made in the early 1980s by Meade et al 1 in the Northwick Park Heart Study (NPHS), the role of fibrinogen as a predictor of primary and secondary ischemic coronary events has been demonstrated by several epidemiological studies. [2][3][4][5] Three meta-analyses have been published on the association between fibrinogen and cardiovascular disease: all agree on the finding that high fibrinogen levels are associated with an increased risk of disease. 6 -8 The last of them 8 reviewed 18 prospective studies on Ϸ4000 cases of coronary heart disease followed for a mean of 8 years: fibrinogen levels in the top third were associated with an odds ratio of 1.8 (95% confidence interval [CI], 1.6 to 2.0). These results definitively confirmed the importance of fibrinogen, because they assemble a large number of prospective studies, weighed for possible confounders.Many pieces of evidence make plausible a causal contribution of fibrinogen to cardiovascular disease. This protein is crucial in the process of thrombus formation and evolution, and its levels are influenced by several conventional risk factors. Fibrinogen is the last target of coagulation: its lysis by thrombin produces soluble fibrin fragments that are then stabilized in a clot by factor XIII. It is a mediator of platelet aggregation and a determinant of plasma viscosity. Fibrinogen is an acute phase protein, synthesized in the liver, the plasma levels of which acutely rise during inflammatory conditions. Fibrinogen levels increase with age, pregnancy, use of oral contraceptives, menopause, and obesity. Smoking habits, infections, hypertension, and diabetes are associated with increased levels of fibrinogen, whereas physical activity, moderate alcohol consumption, and fi...